HUP1000688A2 - Use of trifluoro-phthalimides in the treatment of cancer - Google Patents
Use of trifluoro-phthalimides in the treatment of cancerInfo
- Publication number
- HUP1000688A2 HUP1000688A2 HU1000688A HUP1000688A HUP1000688A2 HU P1000688 A2 HUP1000688 A2 HU P1000688A2 HU 1000688 A HU1000688 A HU 1000688A HU P1000688 A HUP1000688 A HU P1000688A HU P1000688 A2 HUP1000688 A2 HU P1000688A2
- Authority
- HU
- Hungary
- Prior art keywords
- phthalimides
- trifluoro
- cancer
- treatment
- Prior art date
Links
- OOIKNBCJWRKDIF-UHFFFAOYSA-N 4,5,6-trifluoroisoindole-1,3-dione Chemical class FC1=C(F)C(F)=CC2=C1C(=O)NC2=O OOIKNBCJWRKDIF-UHFFFAOYSA-N 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1000688A HUP1000688A2 (en) | 2010-12-23 | 2010-12-23 | Use of trifluoro-phthalimides in the treatment of cancer |
PCT/HU2011/000130 WO2012085608A2 (en) | 2010-12-23 | 2011-12-23 | Use of trifluoro phthalimides for the treatment of cancerous diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1000688A HUP1000688A2 (en) | 2010-12-23 | 2010-12-23 | Use of trifluoro-phthalimides in the treatment of cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
HU1000688D0 HU1000688D0 (en) | 2011-02-28 |
HUP1000688A2 true HUP1000688A2 (en) | 2012-08-28 |
Family
ID=89990139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU1000688A HUP1000688A2 (en) | 2010-12-23 | 2010-12-23 | Use of trifluoro-phthalimides in the treatment of cancer |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP1000688A2 (hu) |
WO (1) | WO2012085608A2 (hu) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0700433A2 (en) * | 2007-06-21 | 2009-03-30 | Avidin Kutato | Compounds influencing development or functioning of cellular vesicular systems particularly lipid droplets, pharmaceutical compositions containing these compounds and use them for treatment of illnesses |
HUP0700432A2 (en) * | 2007-06-21 | 2009-03-30 | Avicor Kft | Compounds for detecting of lipid droplets, compositions for detecting of lipid droplets and method for visualization of cells or cell components |
-
2010
- 2010-12-23 HU HU1000688A patent/HUP1000688A2/hu unknown
-
2011
- 2011-12-23 WO PCT/HU2011/000130 patent/WO2012085608A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012085608A3 (en) | 2012-09-07 |
HU1000688D0 (en) | 2011-02-28 |
WO2012085608A2 (en) | 2012-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201207574B (en) | Phytocannabinoids in the treatment of cancer | |
HRP20171474T1 (hr) | Triazolopirazini kao inhibitori brd4 za uporabu u liječenju raka | |
GB201115711D0 (en) | Phyto-cannabinoids for use in the treatment of cancer | |
GB2495841B (en) | Phytocannabinoids for use in the treatment of breast cancer | |
SG10201508495VA (en) | Combination treatment of cancer | |
HK1198133A1 (en) | Crizotinib for use in the treatment of cancer | |
IL222958A0 (en) | Cancer treatment | |
EP2651894A4 (en) | THIOSEMICARBAZONE COMPOUNDS FOR CANCER TREATMENT | |
GB201011411D0 (en) | Therapeutic compounds and their use | |
LT2872176T (lt) | Karboranilporfirinai, skirti naudoti vėžio gydymui | |
ZA201307058B (en) | Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment | |
ZA201209452B (en) | Gold complexes for use in the treatment of cancer | |
HK1203430A1 (en) | Bisarylsulfonamides useful in the treatment of inflammation and cancer | |
EP2575863A4 (en) | USE OF SPARC MICROENVIRONMENT SIGNATURE IN THE TREATMENT OF CANCER | |
EP2585115A4 (en) | ANTICANCER TREATMENT | |
EP2744786A4 (en) | SUBSTITUTED 2-IMIDAZOLIDINONE AND 2-IMIDAZOLONE AND THEIR USE IN THE TREATMENT OF CANCER | |
EP2578215A4 (en) | USE OF OXALOACETATE FOR THE TREATMENT OF ISCHEMIA | |
EP2547368A4 (en) | METHOD AND COMPOSITIONS FOR CANCER TREATMENT | |
GB201718726D0 (en) | Phytocannabinoids in the treatment of cancer | |
HUP1000688A2 (en) | Use of trifluoro-phthalimides in the treatment of cancer | |
GB201301168D0 (en) | Cancer treatment | |
GB201017356D0 (en) | Combination treatment of cancer | |
IL222870A0 (en) | Use of ccl1 in therapy | |
GB201017354D0 (en) | Treatment of cancer | |
GB201020513D0 (en) | Cancer therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |